We are live on ! Find out more
BIOL

Biolase, Inc.
BIOL

Delisted

BIOL was delisted on the 18th of June, 2024.

Back to rankings

32 hedge funds and large institutions have $27.5M invested in Biolase, Inc. in 2017 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

7% more funds holding

Funds holding: 30 → 32 (+2)

28% less capital invested

Capital invested by funds: $38.5M → $27.5M (-$10.9M)

38% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 8

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
32
Holders Change
+2
Holders Change %
+6.67%
% of All Funds
0.8%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
3
Increased
5
Reduced
8
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TMC
Trellus Management Company
Florida
+$74.2K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$59.4K
3
GF
Gabelli Funds
New York
+$44.5K
4
Goldman Sachs
Goldman Sachs
New York
+$29.7K
5
VKH
Virtu KCG Holdings
New York
+$29.7K

Top Sellers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
-$134K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$89.1K
3
BlackRock
BlackRock
New York
-$74.2K
4
GIP
Granite Investment Partners
California
-$59.4K
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$29.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
T. Rowe Price Associates
26
T. Rowe Price Associates
Maryland
$17K – – –
RJFSA
27
Raymond James Financial Services Advisors
Florida
$15K +$14.8K +1 New
Commonwealth Equity Services
28
Commonwealth Equity Services
Massachusetts
$12K – – –
GC
29
Guggenheim Capital
Illinois
$12K – – –
IA
30
IFP Advisors
Florida
$10K – – –
WS
31
Wedbush Securities
California
$10K – – –
Wells Fargo
32
Wells Fargo
California
$10K – – –
Creative Planning
33
Creative Planning
Kansas
$5K – – –
LTFS
34
Ladenburg Thalmann Financial Services
Florida
$3K – – –
Royal Bank of Canada
35
Royal Bank of Canada
Ontario, Canada
$2K – – –
Manulife (Manufacturers Life Insurance)
36
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1K – – –
FDCDDQ
37
Federation des caisses Desjardins du Quebec
Quebec, Canada
$2 – – –
Jacobs Levy Equity Management
38
Jacobs Levy Equity Management
New Jersey
– -$23K -1 Closed
Bank of America
39
Bank of America
North Carolina
– -$5K – –
TRCT
40
Tower Research Capital (TRC)
New York
– -$3K – –
1
2

BIOL Hedge Fund Activity: Q2 2017 in Review

32 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Biolase, Inc. (BIOL) for Q2 2017, worth a combined $27.5M — down 28% from $38.5M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new BIOL positions and 1 closed out — a net gain of 2 holders — while 5 added to existing stakes and 8 trimmed.

The largest buyer was Trellus Management Company, adding an estimated $74.2K. The largest seller was Consonance Capital Management, cutting an estimated $134K.

  • 32 institutional investors held Biolase, Inc. (BIOL) as of Q2 2017, up from 30 in Q1 2017.
  • Funds reported $27.5M of Biolase, Inc. stock for Q2 2017, down 28% quarter-over-quarter.
  • 3 funds opened new Biolase, Inc. positions in Q2 2017 and 1 closed out, a net change of +2 holders.
  • The largest Biolase, Inc. buyer in Q2 2017 was Trellus Management Company, an estimated $74.2K added.
  • The largest Biolase, Inc. seller in Q2 2017 was Consonance Capital Management, an estimated $134K sold.

Based on aggregated 13F filings for Q2 2017.